$1,000 invested in SpaceX stock 2 months ago is now worth

SpaceX shares have rebounded roughly 31% from about $113 on July 27 to $148.68, though they remain below their $225.64 post-IPO high. The company raised $85.7B in total IPO proceeds at an approximately $1.77T valuation, but initially faced pressure from capital-spending concerns, AI investment needs and lockup expirations. Growth catalysts include the xAI and Anysphere acquisitions, recurring computing agreements, Starlink expansion, and more than $7B in Pentagon awards, including a $1.6B Space Force launch contract through 2027.

Analysis

The relevant question is not whether SPCX has rebounded, but whether public-market investors will assign a premium multiple to a capital-intensive launch/network operator while it absorbs AI assets requiring sustained compute spending. The combination raises the probability of a conglomerate discount: Starlink-like recurring connectivity revenue, government-contract revenue, launch operations and AI infrastructure have different margins, capex profiles and valuation frameworks. Without segment-level disclosure of AI bookings, GPU lease obligations, Starlink churn and free-cash-flow conversion, the claimed AI upside is not independently investable.

Near term, the principal technical risk is residual insider and early-holder supply rather than operating deterioration; a sharp rally can be fragile if float expansion outpaces incremental institutional demand. Over 1-3 months, the decisive catalysts are first post-IPO earnings/guidance, disclosure of capex and stock-based compensation, and any Starship schedule change; these can drive a multiple reset materially larger than ordinary quarterly revenue variance. Over 6-18 months, the structural bull case requires Starlink ARPU expansion and AI compute utilization to rise faster than depreciation, power and financing costs; otherwise the equity becomes a duration-sensitive capex story.

Consensus appears to be treating government awards as high-quality backlog, but these contracts may validate strategic relevance more than they improve consolidated economics: fixed-price execution, launch cadence, and working-capital terms matter. NDAQ has only marginal benefit through trading and listings activity, while SSTK has no clear fundamental read-through. The contrarian opportunity is to avoid extrapolating the recovery until audited segment economics establish that incremental revenue produces incremental free cash flow.

Key Decisions for Investors

• No directional SPCX position before the first fully reported public-company quarter; place an alert for segment revenue, adjusted EBITDA-to-FCF conversion, capex guidance and AI compute commitments. A long is warranted only if Starlink/AI growth is accompanied by improving FCF conversion rather than higher cash burn.
• If SPCX trades back toward its prior peak without audited evidence of AI utilization or a narrowing capex-to-revenue ratio, consider a 1-3 month tactical short or put spread, sized modestly for high-short-interest and headline risk. Cover on guidance showing durable positive FCF, a credible AI backlog disclosure, or a successful major Starship milestone.
• For investors requiring exposure, use a relative-value structure: long a diversified defense/space proxy such as XAR against a small SPCX short after a valuation-driven spike. This retains exposure to defense-space budget strength while isolating SPCX execution, dilution and capex-risk; reassess following the first earnings release.
• Do not infer a trade in NDAQ or SSTK from this development. NDAQ exposure is limited to secondary trading/listing economics and SSTK lacks a demonstrated revenue linkage; wait for measurable volume or commercial partnership evidence.